PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.

PT-141 is a unique peptide in that it stimulates the MC-4R, which is known to produce sexual arousal in the central nervous system and influence sexual behavior[‘], [2].
Studies in mice have shown that agonist binding to MC-4R causes sexual arousal and increased copulation in
‘h males and females|3], [4]. Because PT-141 works via ifferent mechanism than drugs like Viagra, it is possible reat sexual arousal disorders in both men and women t stem from causes other than reduced blood flow to genitals.
A study of men with erectile dysfunction (ED) who did not respond to sildenafil (Viagra) found that roughly one third experienced adequate erection for sexual intercourse with
PT-141 (administered via nasal spray). There was also a strong dose-dependent response in the trial, indicating that PT-141 is indeed effective in certain cases|]. This suggests that PT-141 could offer insight into correcting ED in settings where sildenafil has failed and may offer insight into central causes of hypoactive sexual desire.

Important Notices:

This product is sold for scientific research purposes only.
Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
The quantity on the label refers to the total amount of product inside each vial.
Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
Vial appearance, label, seal and cap colors may vary from product photos.

Disclaimer:
This product is not intended for human or animal consumption. It is exclusively designed for research by qualified professionals. Any potential therapeutic applications should undergo rigorous exploration, validation, and further research, including clinical trials.